TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29565643

Group type: EXPERIMENTAL
Intervention: Keeping the shoulder pads in place
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Keeping the chinstrap in place
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Using a bag-valve mask versus a pocket mask
Number of subjects: 26
Study: 26551445

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 (1 × 10 colony forming units daily)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo (identical appearing)
Number of subjects: 184
Study: 24177146

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive bias modification (CBM-I) training to generate positive interpretations of ambiguous social scenarios
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo control condition generating 50% positive and 50% negative interpretations
Number of subjects: 55

Group type: COMPARATOR
Intervention: Neutral placebo control group generating neutral, non-emotional situations
Number of subjects: 55
Study: 22559011

Group type: EXPERIMENTAL
Intervention: Probiotic comprising two strains of lactobacilli and two strains of bifidobacteria, one capsule daily for 21 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebo, one capsule daily for 21 days
Number of subjects: 0
Study: 20484917

Group type: EXPERIMENTAL
Intervention: semi-standardised acupuncture plus rescue medication (cetirizine)
Number of subjects: 400

Group type: COMPARATOR
Intervention: penetrating sham acupuncture at non-acupuncture points plus rescue medication
Number of subjects: 400

Group type: COMPARATOR
Intervention: rescue medication alone for 8 weeks (standard treatment group)
Number of subjects: 400
Study: 18545766

Group type: EXPERIMENTAL
Intervention: Experimental group 1
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Experimental group 2
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 405

Group type: COMPARATOR
Intervention: Control only
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Positive persuasive strategy
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Moral obligation
Number of subjects: 405
Study: 16048984

Group type: EXPERIMENTAL
Intervention: Nelfinavir alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nelfinavir and efavirenz (combination)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Efavirenz alone
Number of subjects: 0
Study: 12588057

Group type: EXPERIMENTAL
Intervention: Resistance training (exercise program)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-participating anorexics
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Unaffected subjects participating in exercise program
Number of subjects: 21
Study: 10398355

Group type: EXPERIMENTAL
Intervention: Ten-point clock test
Number of subjects: 71

Group type: COMPARATOR
Intervention: Elderly controls
Number of subjects: 71
Study: 7537287

Group type: EXPERIMENTAL
Intervention: risperidone 4 mg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: risperidone 8 mg
Number of subjects: 59

Group type: COMPARATOR
Intervention: clozapine 400 mg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: risperidone (both doses)
Number of subjects: 59

Group type: COMPARATOR
Intervention: clozapine
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: risperidone
Number of subjects: 59
Study: 2045855

Group type: EXPERIMENTAL
Intervention: Carboplatin (400 mg/m2)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Iproplatin (300 mg/m2)
Number of subjects: 120
Study: 7019932

Group type: EXPERIMENTAL
Intervention: 200 mg emepronium bromide 3-times daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31265147

Group type: EXPERIMENTAL
Intervention: EXTOD education programme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pilot study
Number of subjects: 0
Study: 30554211

Group type: EXPERIMENTAL
Intervention: Spiration® Valve System (SVS) and medical management
Number of subjects: 107

Group type: COMPARATOR
Intervention: Standard medical management alone
Number of subjects: 107
Study: 28869885

Group type: EXPERIMENTAL
Intervention: Prognostic index for 6-month mortality
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prognostic index for 12-month mortality
Number of subjects: 0
Study: 26765556

Group type: EXPERIMENTAL
Intervention: Flow sensor
Number of subjects: 110

Group type: COMPARATOR
Intervention: ETCO2 detector
Number of subjects: 110
Study: 25438609

Group type: EXPERIMENTAL
Intervention: High levels of fall-related concerns
Number of subjects: 260

Group type: COMPARATOR
Intervention: Low levels of fall-related concerns
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: High levels of fall-related concerns at 14 months
Number of subjects: 260

Group type: COMPARATOR
Intervention: Low levels of fall-related concerns at 14 months
Number of subjects: 260
Study: 21836528

Group type: EXPERIMENTAL
Intervention: TXA (10 mg/kg at induction followed by 1 mg/kg/h infusion)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 76
Study: 19445057

Group type: EXPERIMENTAL
Intervention: Alkalinized lignocaine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Isotonic saline
Number of subjects: 150

Group type: COMPARATOR
Intervention: Air
Number of subjects: 150
Study: 17891081

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 15152819

Group type: EXPERIMENTAL
Intervention: Dental Floss
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Toothpick Holder
Number of subjects: 55
Study: 11674982

Group type: EXPERIMENTAL
Intervention: BIS monitoring group (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 40
Study: 9299382

Group type: EXPERIMENTAL
Intervention: Standard Stroop stimuli (e.g., the word 'RED' displayed in a green font)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stroop stimuli with colored symbols
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition designed to elicit nonspecific interference (taboo words displayed in color fonts)
Number of subjects: 0
Study: 7924129

Group type: EXPERIMENTAL
Intervention: RCCT (Randomized Concentration-Controlled Trials)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RCCT
Number of subjects: 0

Group type: COMPARATOR
Intervention: RDCT
Number of subjects: 0
Study: 3295553

Group type: EXPERIMENTAL
Intervention: Levothyroxine (n = 28)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (n = 25)
Number of subjects: 53
Study: 31743436

Group type: EXPERIMENTAL
Intervention: Patient Navigator LIVESTRONG Cancer Navigation Services (PN-LCNS)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Patient Navigator only (PN only)
Number of subjects: 288
Study: 29035394

Group type: EXPERIMENTAL
Intervention: A-NKC/A-CD14+HLA-DRDIM ratio of ⩾0.29
Number of subjects: 111

Group type: COMPARATOR
Intervention: A-NKC/A-CD14+HLA-DRDIM ratio of <0.29
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: A-NKC/A-CD14+HLA-DRDIM ratio
Number of subjects: 111
Study: 27517350

Group type: EXPERIMENTAL
Intervention: Lacosamide (LCM) 150mg, b.i.d.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Carbamazepine immediate‐release (CBZ‐IR) 200mg, t.i.d.
Number of subjects: 60
Study: 24837060

Group type: EXPERIMENTAL
Intervention: Hypnobehavioral therapy (HypBe)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hypnobehavioral therapy enhanced by energetic psychotherapy (HypEn)
Number of subjects: 60

Group type: COMPARATOR
Intervention: HypEn
Number of subjects: 60
Study: 23957874

Group type: EXPERIMENTAL
Intervention: Peer‐ and family‐based group therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study: 20659947

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration (TA)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Standard PCI (SP)
Number of subjects: 299
Study: 18779881

Group type: COMPARATOR
Intervention: Histamine skin prick test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Codeine skin prick test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New prick tests after 7 days
Number of subjects: 0
Study: 16781290

Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study: 12531775

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 10726794

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 255

Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Latanoprost (after switching from Timolol)
Number of subjects: 255
Study: 8817300

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 1356175

Group type: EXPERIMENTAL
Intervention: Monthly pulse methylprednisolone for 6 months
Number of subjects: 65

Group type: COMPARATOR
Intervention: Monthly pulse cyclophosphamide for 6 months
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Monthly cyclophosphamide for 6 months followed by quarterly pulse cyclophosphamide for 2 additional years
Number of subjects: 65
Study: 3893195

Group type: EXPERIMENTAL
Intervention: Clonidine (3‐600 micrograms, six hourly)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Chlormethiazole (500‐1000 mg, six hourly)
Number of subjects: 20
Study: 30037309

Group type: EXPERIMENTAL
Intervention: Fat graft enriched with platelet-rich plasma (group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cartilage perichondrium graft (group 2)
Number of subjects: 50
Study: 29341834

Group type: EXPERIMENTAL
Intervention: Carfilzomib, Lenalidomide, and Dexamethasone (KRd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lenalidomide and Dexamethasone (Rd)
Number of subjects: 0
Study: 26771294

Group type: EXPERIMENTAL
Intervention: Curcumin (3 g/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23460415

Group type: EXPERIMENTAL
Intervention: VESTAsync™ Eluting Stent (VES)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (Gen X stent)
Number of subjects: 75
Study: 22313079

Group type: EXPERIMENTAL
Intervention: 1.0 g intravenous paracetamol intraoperatively
Number of subjects: 30

Group type: COMPARATOR
Intervention: 1.0 g oral paracetamol 30 to 60 minutes preoperatively
Number of subjects: 30
Study: 20816966

Group type: EXPERIMENTAL
Intervention: Social exclusion (SE)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Technical default (TD)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Social inclusion (SI)
Number of subjects: 67
Study: 17394063

Group type: EXPERIMENTAL
Intervention: Instrument developed for sedation choice
Number of subjects: 194

Group type: COMPARATOR
Intervention: Standard sedation practice (Control)
Number of subjects: 194
Study: 15382064

Group type: EXPERIMENTAL
Intervention: DRB1*04 tumors
Number of subjects: 52

Group type: COMPARATOR
Intervention: non-DRB1*04 tumors
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: DRB1*07 tumors
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: DR+ tumors
Number of subjects: 52
Study: 11438134

Group type: EXPERIMENTAL
Intervention: Narrow-band UVB
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: UVA
Number of subjects: 73

Group type: COMPARATOR
Intervention: Visible fluorescent light
Number of subjects: 73
Study: 9685104

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (group A, n=60 patients)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard medical therapy (group B, n=20 patients)
Number of subjects: 80
Study: 7924632

Group type: EXPERIMENTAL
Intervention: Melatonin and cortisol circadian rhythms in elderly subjects with dementia
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) suppression test (1 mg orally at 2300)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Synthetic corticotropin (Synacthen 2,500 ng) pulse i.v. injection
Number of subjects: 56
Study: 2625543

Group type: EXPERIMENTAL
Intervention: Endurance tasks at contraction levels of 5, 10, 15, 20, 30, 40, and 50% MVC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Endurance tasks at contraction levels less than 70 N
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Maximal voluntary contraction (MVC) measured at the wrist with elbow at right angle
Number of subjects: 12
Study: 799560

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Timolol plus Hydrochlorothiazide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diuretic (Hydrochlorothiazide)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Beta-receptor blockade (Timolol)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined therapy (Timolol plus Hydrochlorothiazide)
Number of subjects: 20
Study: 30644983

Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT) with cyclophosphamide (200 mg/kg) and antithymocyte globulin (6 mg/kg)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Disease-modifying therapy (DMT) of higher efficacy or a different class than DMT taken during the previous year
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Disease-modifying therapy (DMT)
Number of subjects: 110
Study: 28901892

Group type: EXPERIMENTAL
Intervention: Anthocyanin (ACN) supplementation (320 mg/d)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PBO) treatment
Number of subjects: 16
Study: 25567475

Group type: EXPERIMENTAL
Intervention: Caffeinated sugar-sweetened beverage (C-SSB)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Non-caffeinated sugar-sweetened beverage (NC-SSB)
Number of subjects: 99
Study: 23885658

Group type: EXPERIMENTAL
Intervention: 6% CS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 4% N-9
Number of subjects: 60

Group type: COMPARATOR
Intervention: Universal HEC placebo
Number of subjects: 60
Study: 21310372

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine (1 to 2 mg) administered 2 times during PCI
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 19282342

Group type: EXPERIMENTAL
Intervention: Endurance time (ET) during exercise
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Inspiratory capacity (IC) at rest, isotime, and peak exercise
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Ventilation during exercise
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Dyspnoea intensity at isotime and peak exercise
Number of subjects: 463
Study: 16753388

Group type: EXPERIMENTAL
Intervention: DUR‐8 Elite
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: URF‐P3
Number of subjects: 192
Study: 16392437

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12351451

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 50
Study: 10579068

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noninvasive nuclear imaging (SPECT and PET) and stress echocardiography
Number of subjects: 0
Study: 8775856

Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 25

Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 25
Study: 2148223

Group type: EXPERIMENTAL
Intervention: Isradipine SRO (5 mg) given at either 9 am or 9 pm
Number of subjects: 22
Study: 383311

Group type: EXPERIMENTAL
Intervention: BRL‐10833 (mast cell stabiliser)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31303025

Group type: EXPERIMENTAL
Intervention: Carotid Intima-Media Thickness (IMT)
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Plaque
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Thrombotic occlusion in CLI
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: IMT
Number of subjects: 952

Group type: COMPARATOR
Intervention: IMT thresholds
Number of subjects: 952
Study: 30771329

Group type: EXPERIMENTAL
Intervention: MiECC (Miniaturized Extracorporeal Circulation)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standard Extracorporeal Circulation
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: MiECC
Number of subjects: 128
Study: 28129989

Group type: EXPERIMENTAL
Intervention: Individually tailored risk letter and invitation to attend a no-commitment introductory session run by the local SSS
Number of subjects: 4384

Group type: COMPARATOR
Intervention: Standard generic letter advertising the local SSS
Number of subjects: 4384
Study: 26201254

Group type: EXPERIMENTAL
Intervention: Valsartan (angiotensin II receptor blocker)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 293
Study: 23448396

Group type: COMPARATOR
Intervention: hCG 0 IU/day (Control)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: hCG 50 IU/day
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: hCG 100 IU/day
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: hCG 150 IU/day
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: DHEA (all doses)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: SHBG (all doses)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: AMH (all doses)
Number of subjects: 62
Study: 20965292

Group type: EXPERIMENTAL
Intervention: Rimonabant 20 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 19298950

Group type: EXPERIMENTAL
Intervention: Deep lamellar endothelial keratoplasty (DLEK)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Penetrating keratoplasty (PK)
Number of subjects: 25
Study: 18008201

Group type: EXPERIMENTAL
Intervention: White Light Endoscopy (WLE)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Autofluorescence Endoscopy (AFE)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: WLE followed by AFE
Number of subjects: 51
Study: 15588275

Group type: EXPERIMENTAL
Intervention: Cortisol levels in patients with CFS
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Hormone levels (FSH, LH, estradiol, progesterone) in patients with CFS
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Hormone levels in patients with high depression scores
Number of subjects: 43
Study: 11487293

Group type: EXPERIMENTAL
Intervention: Redundant target visual search
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Analysis of fluctuations in discrimination accuracy at threshold
Number of subjects: 0
Study: 9580774

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 8306829

Group type: EXPERIMENTAL
Intervention: Fecal occult blood testing (six tests offered)
Number of subjects: 27700

Group type: COMPARATOR
Intervention: Control group (no fecal occult blood testing)
Number of subjects: 27700
Study: 2728826

Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene (PTFE) cannulae (n = 11)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Thermoplastic polyether‐urethane (TPEU) cannulae (n = 11)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Polyamide‐ether-elastomer (XLON) cannulae (n = 10)
Number of subjects: 32
Study: 811076

Group type: EXPERIMENTAL
Intervention: Clonazepam (Rivotril(R)) combined with previous anti-epileptic drugs
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo combined with previous anti-epileptic drugs
Number of subjects: 17
Study: 31440031

Group type: EXPERIMENTAL
Intervention: Vaginal Yimaxin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vaginal Utrogestan
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oral Yimaxin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Oral Utrogestan
Number of subjects: 16
Study: 28534417

Group type: EXPERIMENTAL
Intervention: Home-based training with telemonitoring guidance
Number of subjects: 90

Group type: COMPARATOR
Intervention: Centre-based training
Number of subjects: 90
Study: 26044602

Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline 2 mL (Control)
Number of subjects: 90
Study: 24112401

Group type: EXPERIMENTAL
Intervention: Collagenase clostridium histolyticum (CCH) - investigational intralesional injection
Number of subjects: 832
Study: 21577028

Group type: EXPERIMENTAL
Intervention: Lapatinib and Capecitabine
Number of subjects: 293
Study: 18979269

Group type: EXPERIMENTAL
Intervention: 1/0.5 kHz FPA
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: IAD ratio
Number of subjects: 70
Study: 16821181

Group type: EXPERIMENTAL
Intervention: Total Hip Replacement (THR)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (age matched population)
Number of subjects: 73
Study: 15361775

Group type: EXPERIMENTAL
Intervention: Bendrofluazide 2.5 mg daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 11517200

Group type: EXPERIMENTAL
Intervention: Simultaneous pumping with no massage
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Simultaneous pumping with massage
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sequential pumping with no massage
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sequential pumping with massage
Number of subjects: 36
Study: 9313673

Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (20 micrograms)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 8452323

Group type: EXPERIMENTAL
Intervention: Loperamide plus ciprofloxacin
Number of subjects: 88

Group type: COMPARATOR
Intervention: Ciprofloxacin alone
Number of subjects: 88
Study: 3614616

Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 mg orally prior to sleep)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (100 mg infusion throughout the night)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of both steroids
Number of subjects: 0
Study: 30446325

Group type: EXPERIMENTAL
Intervention: Conventional double puncture arthrocentesis
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Single puncture type 2 arthrocentesis
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 26